Lung cancer develops when cells in the lung tissue accumulate genetic damage that causes them to grow uncontrollably. Tobacco smoking causes roughly 80% to 90% of lung cancer cases, but the remaining 10% to 20% occur in people who have never smoked. Understanding the full range of causes helps explain why lung cancer remains one of the most common cancers worldwide.
How Tobacco Smoke Damages Lung Cells
Cigarette smoke contains dozens of cancer-causing chemicals, including polycyclic aromatic hydrocarbons, nitrosamines, aldehydes, benzene, and certain metals. When you inhale smoke, these compounds enter your lung cells and physically bind to your DNA, forming what scientists call “adducts,” small chemical attachments that distort the normal structure of your genetic code. Every time a damaged cell divides, those distortions can translate into permanent mutations.
Two genes are particularly vulnerable. The p53 gene normally acts as a brake on cell growth, forcing damaged cells to either repair themselves or self-destruct. The K-ras gene helps regulate when cells divide. Tobacco carcinogens cause specific, well-documented mutations in both. When p53 loses its ability to stop defective cells and K-ras gets stuck in the “on” position, a cell can begin multiplying without any checks. This doesn’t happen overnight. The latency period between chronic exposure and a diagnosable tumor is typically many years, sometimes decades.
Radon: The Leading Cause After Smoking
Radon is a naturally occurring radioactive gas that seeps into buildings from the soil. It’s colorless and odorless, which means most people have no idea they’re breathing it. The World Health Organization estimates radon causes up to 15% of lung cancers worldwide, and in the United States it contributes to roughly 2,900 lung cancer deaths each year among people who have never smoked.
The EPA recommends taking action when indoor radon levels reach 4 pCi/L or higher. To put the risk in perspective: a person who has never smoked and is exposed to 1.3 pCi/L has about a 2 in 1,000 chance of developing lung cancer. A smoker at the same exposure level has a 20 in 1,000 chance. That tenfold difference illustrates how radon and tobacco multiply each other’s effects. Testing your home is the only way to know your radon level, and mitigation systems can reduce concentrations significantly.
Secondhand Smoke and Air Pollution
Breathing other people’s tobacco smoke is a well-established cause of lung cancer. In the U.S., secondhand smoke is responsible for an estimated 7,300 lung cancer deaths per year among nonsmokers. The mechanism is the same as direct smoking: inhaled carcinogens damage DNA in lung cells. Living with a smoker for many years substantially increases risk.
Outdoor air pollution, particularly fine particulate matter from vehicle exhaust, industrial emissions, and wildfire smoke, also contributes. These tiny particles penetrate deep into lung tissue and trigger chronic inflammation, creating conditions where genetic damage is more likely to take hold.
Workplace Carcinogens
Certain occupations carry elevated lung cancer risk due to prolonged exposure to airborne carcinogens. Asbestos is the most well-known, with a minimum latency period of about 19 years between first exposure and diagnosis. Crystalline silica dust (common in mining, construction, and sandblasting), chromium compounds (with a latency as short as 5 years), and soot exposure (latency around 9 years) are also recognized causes. Workers exposed to diesel exhaust face increased risk as well.
These risks compound with smoking. A smoker who also works around asbestos, for instance, faces a dramatically higher chance of lung cancer than either risk factor alone would predict.
Genetic Mutations and Family History
Not all lung cancers trace back to an environmental exposure you can point to. Some arise from spontaneous genetic mutations that occur during normal cell division, essentially bad luck at the molecular level. A family history of lung cancer increases your own risk even if you’ve never smoked, suggesting inherited genetic factors play a role for some people.
Researchers have identified several key mutations that drive lung cancer growth. The most common include EGFR mutations, ALK rearrangements, ROS1 rearrangements, BRAF mutations, MET exon skipping mutations, and RET fusions. These are somatic mutations, meaning they develop within the tumor itself rather than being inherited at birth, but they help explain why some nonsmokers develop aggressive lung cancers. In a review of over 1,500 patients with advanced lung cancer, EGFR mutations were the most frequent driver, found in roughly 41% of cases, followed by ALK rearrangements in about 14%. Identifying these mutations matters because targeted therapies can now match treatment to the specific genetic error fueling each person’s cancer.
Chronic Lung Disease as a Risk Factor
Existing lung conditions create an environment where cancer is more likely to develop. COPD (chronic obstructive pulmonary disease) and pulmonary fibrosis both involve ongoing inflammation and repeated cycles of tissue damage and repair. Each repair cycle requires cells to divide, and each division is another opportunity for a copying error in the DNA. Smoking is the common thread linking all three conditions: it causes COPD, contributes to fibrosis, and independently causes cancer. But even among nonsmokers, having COPD or pulmonary fibrosis raises lung cancer risk, suggesting that chronic inflammation itself is part of the problem.
Patients with a combination of emphysema and pulmonary fibrosis face an especially high risk, likely because the two types of damage create overlapping biological pathways that promote tumor formation.
E-Cigarettes and Emerging Concerns
E-cigarettes haven’t been in widespread use long enough to directly measure lung cancer rates among vapers, but laboratory and early clinical research raises concerns. The two primary base ingredients in e-liquids, propylene glycol and vegetable glycerin, have been shown to be toxic to lung cells, and toxicity increases with the number of additional flavoring chemicals in the mix. E-cigarette aerosol also contains acrolein, a compound linked to acute lung injury and associated with both COPD and lung cancer. While vaping exposes you to fewer carcinogens than combustible cigarettes, “fewer” is not “none,” and the long-term effects on lung tissue remain an open question given how recently these products became popular.
Why Lung Cancer Takes Years to Appear
One reason lung cancer is so dangerous is the gap between cause and effect. A single mutation rarely causes cancer on its own. Cells need to accumulate multiple genetic errors, typically in both growth-promoting genes and the tumor-suppressor genes meant to catch problems, before they become truly cancerous. This process unfolds over years or decades. For asbestos, the minimum documented latency is 19 years. For smoking, the risk continues climbing with each year of use and remains elevated for years after quitting, though it does decline steadily.
This slow accumulation also explains why lung cancer is most commonly diagnosed in people over 65. It takes time for enough mutations to stack up. By the time a tumor is large enough to cause symptoms like a persistent cough, chest pain, or unexplained weight loss, the underlying genetic damage may have been building for a very long time.